Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
An industry parallel - Dewmar International vs. Monster Beverages
As many may know, Monster Beverage Corp (in its predecessor form) was at one point nearly worthless and filed for bankruptcy many years ago. After a couple of name changes, and after being acquired, it has not only recovered, but has become a monster (excuse the pun) in the beverage industry, currently valued at about $18 billion (with sales of about $2 billion annually).
While it may seem somewhat absurd to compare a tiny OTC company like Dewmar (DEWM) to an industry giant like Monster Beverage Corp, there is a method to my madness. Many years ago, there was simply no 'energy drink' beverage market. The closest thing that existed was drinks that provided energy due to their high sugar content, or caffeinated drinks such as coffee or tea. But the U.S. energy drink market has now grown to more than $12 billion annually, and is expected to break $20 billion by 2017.
As a complement to the energy drink market, we then had a new category of drink, relaxation beverages, emerge in the 2000s. And with the fast paced world, and recurring headlines regarding global conflict, economic challenges, and disease outbreaks, it is no wonder why such a beverage category would be necessary. And who's to say that the newer relaxation drink marker could not grow with a similar trajectory to the energy drink market.
If it the demand for relaxation beverages does explode at some point, Dr. Marco Moran (with his background, determination, and contacts) could be perfectly poised to capture a substantial share of that growing market, and potentially produce a stunning chart for DEWM similar to the monster bev chart below.
I suppose that we'll have to stay tuned for updates from Dr. Moran to see how things progress in the coming weeks and months. As always, simply my opinion.
DEWM
Thanks Elcappy1.
IMO, the VOIS ear mounted hands-free controller could create a revolution in gaming. As was pointed out during a recent CNBC interview, the world currently expects a clunky, bulky, uncomfortable helmet type device to enjoy mind driven gaming. If VOIS can truly deliver with the accuracy and comfort on their final production version of this ear-mounted controller device, I think this company can scale quickly, and become extremely valuable. Additionally, the application of mind-controlled devices goes far beyond the gaming industry.
As one indication of demand within the innovative controller category, more than 24 million units of the Xbox Kinect motion controller have been sold.
If Mind Solutions Inc. (VOIS) could eventually sell just one million units of their ear-mounted mind controller, that would likely equate to more than $125 million in wholesale revenue. But the reality is that the number sold could be one tenth of that (even 100k units), and we'd still likely see an exponential increase in the share price.
Experiments from several years ago have proven that simple primates can use mind control to accomplish tasks. So wouldn't it seem logical that people will be using these techniques to control video games in the near future? And at that point, button controllers (the current standard in the industry), could seem as ridiculously outdated as phones tethered to the wall. When the Mind Solutions Inc. finished product is available for distribution, the upside here could be tremendous. The applications for their small, ear-mounted controller device are endless.
Believe it or not, even monkeys have participated in experiments that use mind controlled devices (see below).
'Monkey Mind-Control Holds Promise for Paraplegics'
An exerpt from the article:
'But there’s a long way to go before these microchips help humans regain control of their limbs. The monkey experiment simply proved a concept, and the mind-controlled movements were very basic. In order to be useful for humans, they’ll need to achieve more complex fine motor control.'
Monkeys Control a Mechanical Arm With Their Thoughts ...
New York Times article:
'Monkeys Think, Moving Artificial Arm as Own' - exerpt:
'Two monkeys with tiny sensors in their brains have learned to control a mechanical arm with just their thoughts, using it to reach for and grab food and even to adjust for the size and stickiness of morsels when necessary, scientists reported on Wednesday.'
Here's a 2008 Video: Monkey uses brain to control a prosthetic arm - YouTube:
It is not uncommon for publicly traded companies to sacrifice bottom line earnings while focusing more on growing their top-line sales (at least, in the early years). Some have brought up Muscle Pharm's lack of profitability, which is a fair point. Especially in light of the fact that the very recent 10-Q restatement has reversed MP's formerly profitable Q2 '14 into a net loss.
While sustainable profitability is an important, long-term measure of a successful enterprise, it is not as important during the early years, when more focus might be placed on sales growth.
Here are just a few (within various industries) of the many companies near a billion dollar valuation (+/- 30%) that have also (just as Muscle Pahrm) booked a net loss for a series of quarters while growing their sales.
AMAG:NASDAQ - booked losses 4 of the past 5 quarters. Sales of around $90 million for the past 12 months. Current market cap of about $720 million.
ACTG:NASDAQ - booked losses 5 of the past 5 quaters. Sales of around $114 million for the past 12 months. Current market cap of around $900 million.
EPAY:NASDAQ - booked losses 4 of the past 4 quarters. Sales of around $300 million for the past 12 months. Current market cap of around $1 billion.
CSII:NASDAQ - booked losses 5 of the past 5 quarters. Sales of around $148 million for the past 12 months. Current market cap of around $960 million.
ELGX:NADAQ - booked losses 3 of the past 4 quarters. Sales of around $140 million for the past 12 months. Current market cap of around $750 million.
LDRH :NASDAQ - booked losses 5 of the past 5 quarters. Sales of around $125 million for the past 12 months. Current market cap of around $890 million.
What each of the above companies has in common with Muscle Pharm is that they have experienced a series of quarterly losses while growing their top-line sales. And in most instances, Wall Street has rewarded their sales growth effort with a relatively high price/sales multiples.
With continued sales growth, I expect that the investment community will assign an ever increasing sales multiple to Muscle Pharm (for market cap valuation purposes).
As always, simply my opinion.
MSLP
Muscle and Strength results for the month of October:
For those unfamiliar with Muscleandstrength.com, it is one of the many popular sites selling supplements on the web.
Here are MP's strong results for the entire month of October 2014:
#1 best selling product: Muscle Pharm's Amino1
#9 best selling product: MP's Arnold Series Iron CRE3
#12 best selling product: Muscle Pharm's Combat Powder
#13 best selling product: Muscle Pharm's Combat Crunch Bars
#21 best selling product: Muscle Pharm's Assault
#24 best selling product: Muscle Pharm's Assault Carnitine Core
#30 best selling product: Muscle Pharm's Fat Loss Bundle
#35 best selling product: MP's Arnold Series Iron Whey
#37 best selling product: Muscle Pharm's BCAA 3:1:2
#41 best selling product: Muscle Pharm's Glutamine
#42 best selling product: MP's FitMiss Ignite
It is also worth noting that for the month of October, Muscle Pharm was the top selling brand on that site, and MPs Arnold Series was the #7 best selling brand (ahead of #8 brand BSN).
link:
https://www.muscleandstrength.com/store/top-sellers.html
MSLP
With some research, I think you will find that they are intending to be a service oriented business. And the service they will be providing will be delivered via their website. So in this case, launching the website is much more meaningful than it would be to a product oriented business (such as a company selling widgets).
Some examples of other companies that use this website-is-the-business model are Ebay, Google, Amazon. The difference with GTRL is that everything will be 100% bitcoin-oriented.
If executed correctly, this could be something really huge.
As always, simply my opinion.
Here's my take on what is going on here. I'll begin with what I have seen with the countdown-to-launch clock. For a couple of weeks, the countdown clock indicated that the official launch would occur on the morning of Tuesday October 28th. Then about 2 or 3 days prior to the originally scheduled launch date/time, an update was made to the countdown clock, where an additional 24 hours was added. That would have placed the new official launch date at the morning of Wednesday October 29th.
As witnessed by those who were watching with eager anticipation of official launch yesterday morning, the countdown timer struck zero and nothing seemed to occur on the website. And now the countdown timer has begun again with tomorrow morning as the launch date/time.
Based upon the two updates to the countdown timer, I am speculating the following:
Either the official launch is very close to happening, and there are just some things causing delays which are so very common with most OTC companies (mgmt of OTC companies are notorious for being late on almost everything that they commit to)
- or -
The delays and changes to the official launch timer are being done to frustrate those GTRL shareholders that have held the shares for a very long time already, and have little patience left to continue holding. If what is going to be launched is anywhere near as big as the hype, then it wouldn't surprise me if insiders wanted some to let go of their positions just prior to the launch. With such a low outstanding share count and float (according to the company filings), the launch of a substantial enterprise website for bitcoin could be worth a whole lot more than the current share price, and therefore it would be understandable that insiders might want to retrieve some of those shares prior to the launch.
With either of the to possibilities above, I would expect the share price to move significantly higher from this level, in the coming months.
As always, simply my opinion.
GTRL
Yes... no bids or asks are currently showing, for GRCU as well other OTC stocks.
After today's update from the company regarding the approval status with the Dept of Ag, I figured it might be a good time to post a rerun of: The Adventures of FPFI - Episode 4:
We will be going significantly higher, from the current share price level.
As always, simply my opinion.
FPFI
*All images are for entertainment purposes only.
Those who are students of the american automotive industry know that at one time there were nearly 2000 automobile manufacturers (in late 1800s to early 1900s). There are now less than a dozen, of any consequence.
One of the keys to successful investing is placing an early bet on the one who will not only survive, but will thrive. And those that invested in the early winners were handsomely rewarded.
In some ways, the cannabis/mj industry resembles the turn-of-the-century automobile industry. Hundreds of companies have entered the space... most of whom will eventually fade away.
But I believe that Green Cures will be one of those survivors, and here's my rationale. In Robert Calkin, we have a pioneer and educator in the cannabis/mj industry. We have a CEO passionate about this industry, as evidenced by him spending several decades becoming an expert and industry guru. Additionally, he is well versed in navigating the complex and constantly changing regulatory requirements.
Investment vision could be defined as the ability to see a future potential empire, even as the foundation is being poured. I think we have a real winner here, and with time the charts will make that point indisputably evident.
As always, simply my opinion.
GRCU
Please note the following, with respect to Muscle Pharm's net quarterly sales data (see image below for actual data, by quarter):
Sales declined sequentially from Q1 2012 to Q2 2012
Sales declined sequentially from Q3 2012 to Q4 2012
Sales declined sequentially from Q2 2013 to Q3 2013
Sales declined sequentially from Q1 2014 to Q2 2014
So I suppose the conclusion one might draw is that despite the fact that sales has not always grown sequentially from quarter to quarter, the total sales in each year has been much larger than the previous year, and comparable quarters are much larger from one year to the next.
I see healthy sales growth in the quarterly numbers, but I guess some might have a different take on the data.
As always, simply my opinion.
MSLP
Thanks sampa. And with the new SC 13G share filings today, it would appear that at least one of the convertible financiers are taking the opportunity to convert some debt into OWOO shares based upon the recent share price low of 0.0033 (and at a discount to that low, of course).
From the looks of things, any retail (open market) investor does not stand a chance here.
New, as of this week (according to the info I was able to find)...
link:
https://who.is/whois/https://www.ikingdomii.com
On October 15th, OWOO had a share price trading low of 0.0033. Since the typical conversion usually occurs at a discount of 30% - 50% off of the the trading low for the measurement period, at least part of the recently obtained $800,000 financing will likely convert at a share price equivalent range of .0017 to .0023 (since I have not seen the agreement specifics, I have made a conversion assumption). We should have a better idea of the specifics of the financing terms of the $800,000 within a future 10-Q of 10-K OWOO filing.
With an assumed converted share cost basis of between .0017 and .0023, the toxic lender/share converter can sell all the way down to that price range and still turn a profit. The unfortunate consequence of selling into that share price range is that the next conversion has an even lower share price bottom, and therefore an even lower share price conversion rate. This vicious cycle usually continues until the share price is so low, that the company resorts to performing a reverse stock split (as an act of desperation) to get the share price back up (where is is again attractive to toxic lenders).
The above phenomenon is often referred to as a toxic debt downward spiral. An one does not have to look too far to find an example of it. One simply has to refer back to the trading price for OWOO about 12 months ago, when precisely the same thing occured.
I know that a sub penny share price was predicted for quite some time, and although it took some time, the predictions turned out to be very accurate. We now have predictions of the stock going into the triple zero range, and it wouldn't surprise me if that were to occur as well.
We may have had a better idea of the terms of the $800k financing, if the company had done what they said they would do and have regular periodic shareholder conference calls, but that is just one of the many things that mgmt has not lived up to.
As always, simply my opinion.
OWOO
Occam's razor: Some here may be familiar with the concept known as 'Occam's razor'. It suggests that 'among competing hypotheses, the one with the fewest assumptions should be selected. Other, more complicated solutions may ultimately prove correct, but—in the absence of certainty—the fewer assumptions that are made, the better.' - wikipedia
One view that has been expressed is that although production facilities have been secured, and a product, packaging and various marketing materials have been developed, the whole chewable juice thing is an elaborate hoax, with there being no real intention of a product launch. I can not argue with certainty that it is not, since the product is not yet available for sale.
I choose to believe, though, that the explanation is much simpler. I choose to believe that the product launch delay has been caused primarily by delays in obtaining the necessary certification(s) from the dept(s) of agriculture, just as the company has stated via recent correspondence.
If the CEO of Fresh Promise Foods had not previously served as the head marketing guy for the Minute Maid division of Coca Cola, I might lean more toward the hoax scenario for an explanation as to the delay. But my gut tells me the plan is actually as stated - to launch the chewable juice product as soon as the required state/fed approvals have been obtained. And once the product actually launches, I believe the stock will move up significantly from the current level.
As always, simply my opinion.
FPFI
Some have questioned Robert Calkin's commitment to GRCU because he has split his time/focus between his duties as CEO of Green Cures and his role as CEO of the Cannabis Career Institute.
What I think needs to be emphasized here is that every single thing Robert is able to accomplish in the way of advancement of the acceptance of mmj/cannabis/hemp (especially regulatory and legislative changes) will have a direct and positive impact on GRCU, since it will continue to open up potential markets for an ever-increasing line of products.
But there is another more subtle (but equally impactful) benefit that GRCU shareholders get as a result of Robert Calkin also serving as CEO of the Cannabis Career Institute.
Many of us are well aware of the OTC CEOs that syphon money, on a regular basis, from the OTC company in which they lead. Many of those CEOs treat the authorized corporate stock as a personal piggy back from which to draw a seemingly endless supply of funds. It is very clear that those shenanigans are not present here. And the fact that Robert Calkin is hard working and enterprising enough to have another source of income, insures that there is no need for him to become that kind of CEO. I think that is the primary explanation for why he was able to accept the modest 4 million GRCU shares provided annually in his employment agreement.
As always, simply my opinion.
GRCU
This may be one of the most company-favorable funding agreements I've ever seen in the OTC.
For starters, there is only a 15% discount applied to the lowest avg trading day bids (I've seen as much as a 50% discount applied). Secondly, the measurement period for the computation of the avg price is only 7 days (the more days, the worse the agrmt). Thirdly, the period covered is 36 months long. This means that Fresh Promise can wait for the share price to recover, and then 'Put' a whole lot of those recovered-price shares to J.P. Carey Enterprises, with a higher cost basis. Fourthly, it provides for more than $1 million, so it is deep funding.
Additionally, the financing is structured as a 3 year 'put' option. For those who are unfamiliar with how a 'Put' option works, it is the right (but not the obligation) to sell a certain number of shares at a certain price. Since FPFI holds the 'Put' option, all power and timing is with FPFI. They can 'put' none of the shares when the stock price is weakest, and 'put' many shares when the stock price is strong.
For this reason, it is far more favorable than a convertible note, where the share price may be in the dumps just as the note due date is approaching.
While there is still some degree of uncertainty with this specific agreement, because the put share price will be determined by 7 days of trading after notice of the intent to put by FPFI, 7 days of uncertainty is far better than the 6 months to a year of share price uncertainty on a typical convertible note.
As always, simply my opinion.
"Effective September 24, 2014, Fresh Promise Foods, Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with J.P. Carey Enterprises, Inc. (“Carey”), whereby the parties also agreed to enter into a registration rights agreement (the “Registration Rights Agreement”). Pursuant to the terms of the Investment Agreement, for a period of thirty-six (36) months commencing on the trading day immediately following date of effectiveness of the Registration Statement (as defined below), Carey shall commit to purchase up to $1,250,000 of the Company’s common stock, par value $0.00001 per share (the “Shares”), pursuant to Puts (as defined below), covering the Registrable Securities (as defined below). The purchase price of the Shares under the Investment Agreement is equal to a fifteen (15%) percent discount to the average of the three lowest closing bids as calculated using the average of the three lowest closing bids during the last seven trading days after the Company delivers to Carey a Put notice in writing requiring Carey to purchase shares of the Company, subject to the terms of the Investment Agreement."
FPFI
Great news, doogie1234. Thanks for letting the group know about this additional item from Green Cures. It would seem that many more items will be available on Amazon shortly.
•••> How many eyes are viewing Amazon?
According to current reported stats, there are hundreds of millions of websites on the internet. And just how popular is Amazon.com? According to Alexa.com (which tracks total web traffic), Amazon.com is the #5 website in the United States, and the #8 website worldwide.
And here's a little more info regarding our newest distribution channel (Amazon.com):
Fascinating Number: Amazon Is Larger Than The Next Dozen Internet Retailers Combined
http://www.forbes.com/sites/timworstall/2013/09/01/fascinating-number-amazon-is-larger-than-the-next-dozen-internet-retailers-combined/
While being on Amazon does not guarantee sales success, it does guarantee exposure. And generally, when a quality product line gets enough exposure, sales develop rather quickly. Based upon this new distribution channel, I would expect the Green Magic line of products to experience an exponential increase in sales in the coming months.
As always, simply my opinion.
Product link:
http://www.amazon.com/Green-Magic-Soothing-Fluid-Ounce/dp/B00N74F7J0/ref=sr_1_18?ie=UTF8&qid=1414067220&sr=8-18&keywords=Green+magic+hemp
GRCU
Now that was funny, MonkMonkey. Along the same lines, each week when Green Cures releases a new product to one of their websites, I'll get a new matching tattoo, the actual size of the product (lol).
All OTC investors/traders hope to stumble upon one of the authentic 'upside-explosive' OTC stocks. Because as we know, getting into the right one can be a financial life-changer. But only a precious few of the thousands of OTC companies have all of the necessary elements to do so.
We are in a new and highly desirable industry/sector. Governmental bodies are making the regulations (and public policy) friendlier every day, providing a constant source of positive news feeds.
We are being led by CEO Robert Calkin, an industry educator and guru, who has come on board with a compensation package that aligns his interest entirely with GRCU shareholders. Additionally, he has the type of connections that can fuel the release of meaningful PRs for years to come.
And best of all, he has begun building a scalable, and potentially profitable entity. And generating a profit eliminates the biggest risk present in most stocks in the OTC world... toxic convertible debt issued to fund an operational loss, leading to large scale dilution and thus share price destruction.
The green movement is here to stay. And it goes far beyond cannabis/medical mj formulations. The movement also encompasses eco-friendly household products, such as the all natural hemp based products that Green Cures offers at the allbotanical.com web store.
I believe we have something really rare here.
As always, simply my opinion.
GRCU
I can't argue with your first point below, as it represents sound logic. But what this really boils down to, with respect to the old Triton liabilities obligations, is contract law.
The transaction by which Green Cures took over the publicly traded entity (shell) formerly known as Triton was executed via a contract agreement. And there is absolutely no ambiguity in which party would be responsible for 100% of the Triton liabilities/obligations, according to that transaction agreement. The party responsible is to be the same party to which all assets were transferred over, Privileged World Travel.
You know very well that what the attorney opinion letter offered was a CYA type statement. There is not a court in the land (that I am aware of) that would hold one party responsible for the liabilities and obligations when all of the associated assets (ip and otherwise) were transferred to another entity.
BTW, congrats on GRCU holding up very well indeed after several green days.
Here's clause 2.6 of the agreement between Green Cures and Triton, which speaks directly to the assumption of all of Triton's liabilities (financial obligations). It appears on page 3 of 10. I have included a link to the original filing for your convenience.
"2.6 Purchase of Assets, Assumption of Liabilities of Triton by Privileged World Travel Club, Inc. Pursuant to a separate agreement attached hereto as Exhibit A, Privileged World Travel Club, Inc. ("Privileged") has purchased all of the assets and assumed all liabilities and obligations of Triton, including any and all outstanding debts, notes, contracts, and other obligations of Triton, and that the Purchaser shall not be liable in any way for any debt or obligation of Triton, whether known or unknown, disclosed or undisclosed, including but not limited to any note, debt, or liability due as of the date of Closing."
http://www.otcmarkets.com/financialReportViewer?symbol=GRCU&id=119102
Thanks mrcheap. Perhaps if I make enough off of this stock, I'll spring for the production of an animated series based upon GRCU (lol).
Thanks CA$HBAG$. Just trying to help keep the mood upbeat here in GRCU-town until the real money is made.
Here's a little more info regarding our newest distribution channel (Amazon.com):
Fascinating Number: Amazon Is Larger Than The Next Dozen Internet Retailers Combined
http://www.forbes.com/sites/timworstall/2013/09/01/fascinating-number-amazon-is-larger-than-the-next-dozen-internet-retailers-combined/
GRCU
According to current reported stats, there are hundreds of millions of websites on the internet. And just how popular is Amazon.com? According to Alexa.com (which tracks total web traffic), Amazon.com is the #5 website in the United States, and the #8 website worldwide.
While being on Amazon does not guarantee sales success, it does guarantee exposure. And generally, when a quality product line gets enough exposure, sales develop rather quickly. Based upon this new distribution channel, I would expect the Green Magic line of products to experience an exponential increase in sales in the coming months.
As always, simply my opinion.
link:
http://www.alexa.com/siteinfo/amazon.com
GRCU
In recent days, some have been somewhat critical of Robert Calkin for splitting his focus between his duties as CEO of Green Cures (GRCU) and his role as CEO of the Cannabis Career Institute.
What I think needs to be emphasized here is that every single thing Robert is able to accomplish in the way of advancement of the acceptance of mj/mmj/cannabis/hemp will have a direct and positive impact on GRCU.
But there is another more subtle (but equally impactful) benefit that GRCU shareholders get as a result of Robert Calkin also serving as CEO of the Cannabis Career Institute.
Many of us are well aware of the OTC CEOs that syphon money, on a regular basis, from the OTC company in which they lead. Many of those CEOs treat the authorized corporate stock as a personal piggy back from which to draw a seemingly endless supply of funds. It is very clear that this is not the case here. And the fact that Robert Calkin is hard working and enterprising enough to have another source of income, insures that there is no need for him to become that kind of CEO. And I think that is the primary explanation for why he was able to accept the modest 4 million GRCU shares provided annually in his employment agreement.
As always, simply my opinion.
GRCU